Next 10 |
home / stock / crrtf / crrtf news
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has signed an exclusive distribution agreement (the “Agreement&...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agree...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Oc...
2024-05-08 10:06:54 ET More on Crescita Therapeutics Financial information for Crescita Therapeutics Read the full article on Seeking Alpha For further details see: Crescita Therapeutics GAAP EPS of -C$0.03, revenue of C$4.9M
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2024 (“Q1-20...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the fourth quarter and fiscal year ended December 31,...
2023-11-08 09:11:38 ET More on Crescita Therapeutics Crescita Therapeutics announces approval of normal course issuer bid Financial information for Crescita Therapeutics For further details see: Crescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03M
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“ Crescita ” or the “ Company ”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 202...
2023-08-29 08:03:21 ET Crescita Therapeutics ( OTCPK:CRRTF ) Tuesday announced that the Toronto Stock Exchange has approved the company’s proposed normal course issuer bid to purchase up to a maximum of 1,821,616 common shares for cancellation, representing about 10% of its pub...
2023-08-09 12:45:30 ET Crescita Therapeutics press release ( OTCPK:CRRTF ): Q2 GAAP EPS of -C$0.01. Revenue of C$5.2M (-20.1% Y/Y). Segment revenue is expected to be materially lower in the second half of 2023. For further details see: Crescita Therapeutics GAAP ...
News, Short Squeeze, Breakout and More Instantly...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has signed an exclusive distribution agreement (the “Agreement&...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has concluded the asset purchase agreement (the “Purchase Agree...
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Oc...